Combat & Casualty Care

Q4 2016

Military Magazines in the United States and Canada, Covering Combat and Casualty Care, first responders, rescue and medical products programs and news\Tactical Defense Media

Issue link:

Contents of this Issue


Page 18 of 31

Navy Medicine Milestone Naval Medical Center San Diego recently debuted its latest advancement in patient care when Ophthalmologists here performed their first Femtosecond Laser-assisted Cataract Surgery (FLACS) - the first ever performed at a military medical facility. "FLACS offers many benefits over the conventional Phacoemulsification Cataract Surgery (PCS), such as increased precision, improved effective lens positioning, and less damage to surrounding tissue. Cataract surgery has evolved greatly over the past two decades and these advances have resulted in increased safety, faster recovery, and outstanding visual outcomes providing a better experience for our patients," said U.S. Navy Capt. Frank Bishop, lead Ophthalmologist at NMCSD, adding that FLACS uses laser energy to perform many of the steps of cataract surgery, providing surgeons with unprecedented control and accuracy. Most modern cataract surgery is microsurgery performed by using phacoemulsification, which requires small incisions (wounds) to the eye using a small scalpel-like instrument and the use of a small ultrasonic device to break up and remove a cloudy lens, or cataract, from the eye. In FLACS, the laser makes the wounds, and begins the process of breaking up the cataract lens. Use of the laser increases the precision of these steps. Additionally, the FLACS procedure offers the surgeon the ability to treat astigmatism by making precision corneal incisions that optimize the eye shape and enhance vision. More info: Fish Skin Solution for Burn Trauma Kerecis™, a company which uses fish skin to heal human wounds and tissue damage, this past summer presented clinical results demonstrating the efficacy of its fish-skin technology for treating battlefield wounds. The presentations took place at the Military Health System Research Symposium (MHSRS) in August. Casualties caused by improvised explosive devices have increased in frequency, size and severity in the past decade. Such casualties, which primarily affect the unprotected areas of the body, are difficult to treat under battlefield conditions. The number of burns from activities in current theatres of operations has almost quadrupled, making their effective medical treatment even more important to the military. Kerecis is working on several projects with Department of Defense (DOD) entities where the advantages of using fish skin for skin-graft substitution and sparing are being investigated for front-line deployment. Kerecis wound- care product is now available for U.S. Veterans through the Government Services Administration (GSA). More info: New Spec Ops Medical Course A NATO Special Operations Combat Medic (NSOCM) pilot course debuted at the International Special Training Centre (ISTC) on Oct. 3, 2016. The newly developed 22-week course will take international special operations forces (SOF) and operators with basic combat lifesaver skills and train them to be combat medics who are able to sustain casualties up to 36 hours. The NSOCM pilot course will cover 174 NATO-recognized critical tasks in trauma and non-trauma clinical medicine, injuries, illnesses and conditions; and it comes after ISTC's Advanced Medical First Responder Course that teaches initial treatment and care for a patient on a battlefield. This multinational NSOCM course will teach theoretical and tactical medicine to 24 students annually, during nine modules taught by international guests, special topic experts and ISTC instructors. The pilot course began with students from Austria, Belgium, Germany, Greece, Italy, the Netherlands, Norway, Poland, Switzerland, and the United States. More info: New Experts Join Drug Delivery Innovator Portal Instruments, Inc., an emerging leader in the development of innovative drug delivery systems, has announced that Robert Langer, Sc.D., MIT Institute Professor, and Peter Hunter, Ph.D., University of Auckland Distinguished Professor have joined the company's Scientific Advisory Board. "We are thrilled to welcome two esteemed biotechnology leaders, Professor Robert Langer and Professor Peter Hunter, to our team," said Dr. Patrick Anquetil, Chief Executive Officer of Portal Instruments. "We will benefit greatly from their combined and extensive expertise in drug delivery, physiological modeling, and medical device development, as we transition our efforts from research and development to clinical studies and future commercialization." Professors Langer and Hunter will join current Scientific Advisory Board Chair, Ian Hunter, Ph.D., co-founder of Portal Instruments and MIT Hatsopoulos Professor of Mechanical Engineering, as Portal continues to develop a digitally-controlled, needle-free drug injection system to simultaneously transform the delivery of modern medicines and improve the patient experience. Anquetil continued, "We look forward to the insights and contributions Professors Langer and Hunter will make, to push our device to the next level. We believe their unique perspectives with regard to the intricacies of delivery physiology, design for inherent patient variability, and the implementation of clinical investigations will provide a strong benefit to the company." More info: Winter 2016/2017 | Combat & Casualty Care | 17 MedTech

Articles in this issue

Links on this page

Archives of this issue

view archives of Combat & Casualty Care - Q4 2016